Showing results (271-280 of 285) with videos related to
Sort By:
Pageof 29
NAR Cancer|February 4, 2025
Histone H3E50K remodels chromatin to confer oncogenic activity and support an EMT phenotypeKirti Sad, Dorelle V Fawwal, Celina Y Jones, et al.Frontiers in Cell and Developmental Biology|January 31, 2022
HDAC6 Interacts With Poly (GA) and Modulates its Accumulation in c9FTD/ALSGiulia Del Rosso, Yari Carlomagno, Tiffany W Todd, et al.Journal of the American College of Radiology : JACR|November 6, 2018
ACR Appropriateness Criteria® Sinusitis-Child, Aylin Tekes, Susan Palasis, et al.Journal of the American College of Radiology : JACR|May 6, 2017
ACR Appropriateness Criteria® Back Pain-Child, Timothy N Booth, Ramesh S Iyer, et al.Neuro-Oncology|February 25, 2021
A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium studyJason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, et al.Science (New York, N.Y.)|October 6, 2022
Two FTD-ALS genes converge on the endosomal pathway to induce TDP-43 pathology and degenerationWei Shao, Tiffany W Todd, Yanwei Wu, et al.Nature Communications|April 21, 2022
Neutron-upscattering enhancement of the triple-alpha processJ Bishop, C E Parker, G V Rogachev, et al.Journal of the American College of Radiology : JACR|May 6, 2019
ACR Appropriateness Criteria® Suspected Spine Trauma-Child, Nadja Kadom, Susan Palasis, et al.Annals of the Rheumatic Diseases|May 27, 2022
The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonistMicol Romano, Z Serap Arici, David Piskin, et al.Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2022
The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor AntagonistMicol Romano, Z Serap Arici, David Piskin, et al.Pageof 29